Stockscreener 앱 받기
0.7809
6.29%
0.0462
시간 외 거래:
.78
-0.0009
-0.12%
Nuwellis Inc 주식(NUWE)의 최신 뉴스
Nuwellis Inc (NASDAQ: NUWE) Share Price, NUWE Stock News, NUWE Share Price & Updates - Kalkine
Nuwellis, Inc. Announces First Quarter 2026 F - Moomoo
NUWE|Nuwellis Inc|Price:0.889|Chg%:-0.100 - TradingKey
Nuwellis, Inc. SEC Filing (Aug 27, 2026) - Stock Titan
NUWE Stock Slides As Nuwellis Strikes New Pediatric Deals - timothysykes.com
Nuwellis posts updated investor presentation highlighting Aquadex growth, 20% H1 revenue rise - tradingview.com
Biotech Pre-Market Movers: NUWE, SMMT Surge; SYRE, PFSA Sink - RTTNews
Nuwellis enters co-promotion deal for cardiac monitoring device By Investing.com - Investing.com Nigeria
Nuwellis Expands Critical Care Portfolio Through Strategic Commercial Agreement with Atrility Medical - manilatimes.net
Nuwellis enters co-promotion deal for cardiac monitoring device - Investing.com
NUWE Should I Buy - Intellectia AI
Nuwellis study shows epoprostenol safe for pediatric Aquadex therapy - scanx.trade
Nuwellis (NUWE) Momentum: Posts a 4.27% Loss to $1.12; Level Watch: the Price Remains Bounded by the Supplied Support and Resistance in the Latest ReadingAdvance Decline Line - vinanet.vn
Nuwellis (NUWE) Technicals: Slides 1.68% to $1.17 on the Day; Technical Setup: the $1.11 to $1.23 Range Remains in Focus under the Current SnapshotSuperTrend - dars.gov.et
Armistice Capital (NUWE) trims Nuwellis ownership to a 4.99% disclosed stake - Stock Titan
Nuwellis Inc (NUWE) (Q2 2026) Earnings Call Highlights: Revenue Surges 14% and Installed Base Expands - GuruFocus
Nuwellis Inc (NUWE) (Q2 2026) Earnings Call Highlights: Revenue Surges 14% and Installed Base ... - Yahoo Finance UK
Nuwellis Posts 14% Revenue Jump in Q2 2026, Misses on EPS - AlphaStreet
Nuwellis, Inc. (NASDAQ: NUWE) lifts Q2 2026 revenue and margin but stays unprofitable - Stock Titan
Nuwellis Reports Q2 2026: Revenue $2.0M, Gross Margin 76%, Net Loss $4.8M - TradingView
Nuwellis (NASDAQ: NUWE) boosts revenue, flags going concern and Nasdaq risks - Stock Titan
Nuwellis Q2 Results: Revenue Up 14% YoY, Gross Margin Expands To 76% - scanx.trade
Earnings call transcript: Nuwellis posts higher revenue in Q2 2026 as loss narrows - Investing.com Nigeria
NUWE: Q2 revenue up 14% year-over-year, gross margin at 76%, and net loss reduced to $4.8 million - TradingView
Transcript : Nuwellis, Inc., Q2 2026 Earnings Call, Aug 13, 2026 - marketscreener.com
Nuwellis Q2 2026 Earnings Call Transcript - Benzinga
Q2 2026 Nuwellis Inc Earnings Call Transcript - GuruFocus
Nuwellis Reports Second Quarter 2026 Financial Results and Business Highlights Focused on Double Digit Revenue Growth and Expanded Gross Margin - marketscreener.com
BRIEF-Nuwellis Q2 EPS USD -26.64 - TradingView
Press Release: Nuwellis Reports Second Quarter 2026 Financial Results and Business Highlights Focused on Double Digit Revenue Growth and Expanded Gross Margin - Moomoo
Nuwellis, Inc. (NUWE) stock price, news, quote and history - Yahoo Finance UK
NUWE Q2'26 Earnings: EPS estimate is (23.80) USD - TradingView
Nuwellis partners with Philips Capsule to connect Aquadex platform to hospital EHR systems - Bitget
Nuwellis Announces Digital Transformation Program for Aquadex SmartFlow System with Philips Capsule Integration - Quiver Quantitative
Nuwellis Accelerates Digital Transformation of the Aquadex® Platform with EHR Connectivity and Enhanced User Interface - The Manila Times
Nuwellis Announces Digital Transformation of the Aquadex Smartflow System with Ehr Connectivity and Enhanced User Interface - marketscreener.com
NUWE Q1 2026 Earnings: Massive EPS Miss Triggers 4.7% Share DeclineEPS Growth Report - vinanet.vn
Q&A: Building the next generation of cardiorenal care: An interview with Nuwellis - Digital Journal
Certain Common Stock of Nuwellis, Inc. are subject to a Lock-Up Agreement Ending on 8-AUG-2026. - marketscreener.com
Orca Capital (NUWE) discloses 7.0% Nuwellis ownership and warrant blocker - Stock Titan
Certain Stock Options of Nuwellis, Inc. are subject to a Lock-Up Agreement Ending on 8-AUG-2026. - marketscreener.com
Nuwellis appoints Dale Brady as principal R&D engineer By Investing.com - Investing.com UK
Nuwellis, Inc. (NUWE) investors detail 4.7% warrant-based ownership stake - Stock Titan
Nuwellis appoints Dale Brady as principal R&D engineer - Investing.com
Medical Device Engineer With More Than 25 Years' Experience Joins Nuwellis - Stock Titan
NUWE Q2'26 Earnings: revenue estimate is 2.42M USD - tradingview.com
Nuwellis appoints Dale Brady principal R&D engineer - Bitget
Nuwellis (NUWE) investor reports 6.2% stake via shares and capped warrants - Stock Titan
Nuwellis, Inc. Announces Appointment of Dale Brady to Principal R&D Engineer - marketscreener.com
NUWE Stock Whipsaws As Growth, Patents And Volatility Collide - StocksToTrade
Nuwellis plans to expand Aquadex system capabilities By Investing.com - Investing.com South Africa
Nuwellis plans to expand Aquadex system capabilities - Investing.com
Nuwellis Announces Next-Generation Aquadex Platform Strategy to Expand Future Critical Care Applications - The Manila Times
0.86%
0.13%
자본화:
|
볼륨(24시간):